Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

204
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
204
Methods of Medium Optimization01:28

Methods of Medium Optimization

15
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interactions between sleep difficulties and clinical features in children with rare genetic syndromes: a structural equation modelling approach.

BMC pediatrics·2026
Same author

Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia (SILDI-SAFE): A Randomized Controlled Trial.

The Journal of pediatrics·2026
Same author

Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.

Journal of clinical pharmacology·2026
Same author

Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infants.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Pharmacokinetics, safety and preliminary efficacy study of montelukast in critically ill infants with developing bronchopulmonary dysplasia (PRISM).

Contemporary clinical trials communications·2026
Same author

Pharmacoepidemiology of Antiviral Treatment for Congenital Cytomegalovirus in Neonates.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026

Related Experiment Video

Updated: Mar 24, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.

Amanda England1, Kelly Wade2, P Brian Smith3

  • 1Division of Neonatal-Perinatal Medicine, The University of North Carolina at Chapel Hill, N.C. Memorial Hospital, 101 Manning Drive, CB#7596, Chapel Hill, NC 27599-7596, USA.

Contemporary Clinical Trials
|March 13, 2016
PubMed
Summary

The Pediatric Trials Network (PTN) enhances pediatric drug trial efficiency and safety. Innovative methods like sparse sampling and standardized adverse event reporting improve participation and drug safety in children.

Keywords:
Adverse eventsOrganizational improvementsPediatric drug trials

More Related Videos

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.7K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.7K

Area of Science:

  • Pediatric Pharmacology
  • Clinical Trial Design
  • Drug Safety in Children

Background:

  • Pediatric drug trials present unique challenges.
  • The Eunice Kennedy Shriver National Institute of Child Health and Human Development established the Pediatric Trials Network (PTN) in 2010.
  • The PTN aims to improve pediatric drug development.

Purpose of the Study:

  • To review the strategies employed by the PTN to optimize operational efficiencies in pediatric drug trials.
  • To highlight methods that increase both the efficiency and safety of pediatric drug trials.
  • To discuss improvements in adverse event reporting for neonatal drug trials.

Main Methods:

  • Implementation of innovative techniques such as sparse and scavenged blood sampling.
  • Utilizing opportunistic study designs to increase trial participation.
  • Development of a standardized adverse event table for neonatal drug trials.

Main Results:

  • Increased participation in pediatric clinical trials.
  • Enhanced consistency in adverse event reporting for neonatal drug studies.
  • Optimization of operational efficiencies in pediatric drug research.

Conclusions:

  • The PTN has successfully developed and implemented strategies to improve pediatric drug trials.
  • Innovative methodologies are crucial for increasing efficiency and safety in pediatric research.
  • The PTN's work contributes to the safer use of drugs in children.